Wood to Expand Biopharma Manufacturing Hub in South Korea

Pharma Wood to Expand Biopharma Manufacturing Hub in South Korea

2024-04-22 Source: Press release John Wood Group 1 min Reading Time

Related Vendors

Glatt Ingenieurtechnik GmbH

EDL Anlagenbau Gesellschaft mbH

Italvacuum, Srl

John Wood Group PLC

Leading biopharmaceutical firm Celltrion has selected Wood to expand its Songdo biopharma manufacturing hub in Incheon, South Korea. Wood will provide detailed engineering design for a new facility that will increase manufacturing capacity of biological medicines by eight million liquid vials annually.

Wood has been selected by leading biopharmaceutical firm, Celltrion, to expand its Songdo biopharma manufacturing hub in Incheon, South Korea.
(Source: Pixabay)

Aberdeen/UK – Wood has been selected by leading biopharmaceutical firm, Celltrion, to expand its Songdo biopharma manufacturing hub in Incheon, South Korea. Under this contract, Wood will provide detailed engineering design for a new facility that will increase manufacturing capacity of biological medicines by eight million liquid vials per year, helping meet global demand for biopharmaceutical drug products.

Supporting Celltrion to expand its product pipeline and secure manufacturing capacity, Wood’s leading process engineering design capabilities will help Celltrion enhance production efficiency and reduce downtime transitioning equipment from one product to another, resulting in facility operational cost savings.

Jim Goff, Senior Vice President of Life Sciences at Wood said: “Celltrion’s new facility will support secure, stable supply of life-changing medicines to help treat cancer, autoimmune diseases and neurological disorders. We’re incredibly proud to be selected as the engineering partner of choice for such a globally significant project.

“We take pride in our strong, predictable project delivery held at the highest safety and quality standards. Our differentiated process design expertise brings the agility needed to help Celltrion achieve new efficiencies in production, time and costs. We are supporting their commitment to expand global access to innovative biologics products for a healthier world.”

The project will be delivered by Wood’s global Life Sciences experts in Europe and India and will conclude in Q3 2024, with commercial operation set to begin in 2027.

(ID:50008077)

Subscribe to the newsletter now

Don't Miss out on Our Best Content

Business E-mail

Please enter a valid mailadress.

By clicking on „Subscribe to Newsletter“ I agree to the processing and use of my data according to the consent form (please expand for details) and accept the Terms of Use. For more information, please see our Privacy Policy.

Stand vom 23.03.2021

Naturally, we always handle your personal data responsibly. Any personal data we receive from you is processed in accordance with applicable data protection legislation. For detailed information please see our privacy policy.

Consent to the use of data for promotional purposes

I hereby consent to Vogel Communications Group GmbH & Co. KG, Max-Planck-Str. 7/9, 97082 Würzburg, Germany, including any affiliated companies according to §§ 15 et seq. AktG (hereafter: Vogel Communications Group) using my e-mail address to send editorial newsletters. A list of all affiliated companies can be found here

Newsletter content may include all products and services of any companies mentioned above, including for example specialist journals and books, events and fairs as well as event-related products and services, print and digital media offers and services such as additional (editorial) newsletters, raffles, lead campaigns, market research both online and offline, specialist webportals and e-learning offers. In case my personal telephone number has also been collected, it may be used for offers of aforementioned products, for services of the companies mentioned above, and market research purposes.

In case I access protected data on Internet portals of Vogel Communications Group including any affiliated companies according to §§ 15 et seq. AktG, I need to provide further data in order to register for the access to such content. In return for this free access to editorial content, my data may be used in accordance with this consent for the purposes stated here.

Right of revocation

I understand that I can revoke my consent at will. My revocation does not change the lawfulness of data processing that was conducted based on my consent leading up to my revocation. One option to declare my revocation is to use the contact form found at https://contact.vogel.de. In case I no longer wish to receive certain newsletters, I have subscribed to, I can also click on the unsubscribe link included at the end of a newsletter. Further information regarding my right of revocation and the implementation of it as well as the consequences of my revocation can be found in the data protection declaration, section editorial newsletter.